These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 4853308)

  • 1. MCG101-AA, a new ascites tumour in C57 mice. 2. Protocol of vivo transplantation studies in comparison with the solid (SS) and solid ascites (AS) tumours.
    Hagmar B
    Acta Pathol Microbiol Scand A; 1974 May; 82(3):369-78. PubMed ID: 4853308
    [No Abstract]   [Full Text] [Related]  

  • 2. MCG101-AA, a new ascites tumour in C57 mice. 3. Studies of spontaneous metastasis formation from the resectable solid ascites tumour in comparison with the solid tumour of origin.
    Hagmar B
    Acta Pathol Microbiol Scand A; 1974 May; 82(3):379-85. PubMed ID: 4853309
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of HSP47 during the transition from solid to ascitic form of Sarcoma 180 in vivo.
    Shirakami T; Tsuzuki T; Iijima H; Ishikawa Y; Kiyosuke YI; Morino M; Yoshimura M; Yoshikumi C
    In Vivo; 1995; 9(5):509-12. PubMed ID: 8900931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MCG101-AA, a new ascites tumour in C57 mice. 1. Induction procedures and some cytological and physicochemical characteristics.
    Hagmar B
    Acta Pathol Microbiol Scand A; 1974 May; 82(3):358-68. PubMed ID: 4853307
    [No Abstract]   [Full Text] [Related]  

  • 5. Corynebacterium-induced protection against artificial pulmonary metastases of a syngeneic fibrosarcoma in mice.
    Milas L; Hunter N; Withers HR
    Cancer Res; 1974 Mar; 34(3):613-20. PubMed ID: 4590922
    [No Abstract]   [Full Text] [Related]  

  • 6. MCG101-AA, a new ascites tumour in C57 mice. 4. Influence of enzyme treatment on transplantability and some in vitro characteristics.
    Hagmar B; Ryd W
    Acta Pathol Microbiol Scand A; 1975 May; 83(3):328-38. PubMed ID: 1155101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour cell volume changes in vivo induced by heparin.
    Norman M; Norrby K
    Pathol Eur; 1971; 6(3):268-77. PubMed ID: 5114236
    [No Abstract]   [Full Text] [Related]  

  • 8. Metastasis spread from syngeneic murine tumours. Establishment of a test protocol for comparisons between ascites tumours and their progenitors.
    Hagmar B; Ryd W
    Acta Pathol Microbiol Scand A; 1978 May; 86(3):231-9. PubMed ID: 707099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulating influence of bacillus Calmette-Guérin on immunity to polyoma tumors and spontaneous leukemia.
    Lemonde P; Dubreuil R; Guindon A; Lussier G
    J Natl Cancer Inst; 1971 Nov; 47(5):1013-24. PubMed ID: 4330795
    [No Abstract]   [Full Text] [Related]  

  • 10. Hematogenous dissemination of tumour cells and metastases formation in Ehrlich ascites tumour.
    Kiseleva NS; Magamadov YC
    Neoplasma; 1972; 19(4):257-75. PubMed ID: 5054530
    [No Abstract]   [Full Text] [Related]  

  • 11. Influence of tumor antigen on maintenance versus depression of tumor-specific immunity.
    Vaage J
    Cancer Res; 1973 Mar; 33(3):493-503. PubMed ID: 4689898
    [No Abstract]   [Full Text] [Related]  

  • 12. [Mesotheliomas in syrian hamster. 3. Establishment of transplantation lines in solid and ascites form (author's transl)].
    Arnold W; Bender E
    Arch Geschwulstforsch; 1973; 42(2):107-19. PubMed ID: 4763856
    [No Abstract]   [Full Text] [Related]  

  • 13. Enhanced growth of fibrosarcoma in mice treated with phytohemagglutinin.
    Wagener DJ
    Cancer Res; 1973 Jun; 33(6):1295-300. PubMed ID: 4718679
    [No Abstract]   [Full Text] [Related]  

  • 14. Modifications of the metastasizing process through polypassage of tumoral fragments.
    Dumitrescu S
    Arch Immunol Ther Exp (Warsz); 1967; 15(5):801-5. PubMed ID: 5595082
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of xenogenic and allogeneic tumor cells on experimental metastasis with Ehrlich carcinoma.
    Hasegawa Y; Irikura T; Mizuno DI
    Chem Pharm Bull (Tokyo); 1970 Nov; 18(11):2322-6. PubMed ID: 5494853
    [No Abstract]   [Full Text] [Related]  

  • 16. Mouse SaI sarcoma tumor model.
    Ostrand-Rosenberg S
    Curr Protoc Immunol; 2001 May; Chapter 20():Unit 20.3. PubMed ID: 18432776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transplantability and metastasibility of an MCA-induced sarcoma in nude mice. Influence of transfer of thymus cells and adoptive immunity.
    Boeryd B; Suurküla M
    Acta Pathol Microbiol Scand A; 1977 Sep; 85(5):745-50. PubMed ID: 920188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of lysolecithin and analogs on mouse ascites tumors.
    Tarnowski GS; Mountain IM; Stock CC; Munder PG; Weltzien HU; Westphal O
    Cancer Res; 1978 Feb; 38(2):339-44. PubMed ID: 620405
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative studies of the cytostatic effect of a new N-Lost derivative "IMET 3393" and Endoxan in 3 experimental mice tumors (Ehrlich ascites carcinoma, sarcoma 180 solid, leukemia LAJ I)].
    Schnabel R; Jungstand W; Gutsche W; Grimm H; Fritsch S
    Acta Biol Med Ger; 1967; 19(4):543-58. PubMed ID: 5596676
    [No Abstract]   [Full Text] [Related]  

  • 20. Morphology of ascites sarcoma RAB I of the mouse.
    Fritsch S; Heinecke H; Jungstand W
    Neoplasma; 1969; 16(2):195-204. PubMed ID: 4309837
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.